in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex Signs API Manufacturing Deal, to Expand Production Capacity
8:59 AM MDT | August 15, 2012 | Deepti Ramesh
Cambrex (East Rutherford, NJ) says it has entered into an agreement to supply an active pharmaceutical ingredient (API) for a customer's Phase 3 program during 2013–2014. The name of the customer was not disclosed. Cambrex, under this non-exclusive supply arrangement, will manufacture and deliver Phase 3 and prelaunch quantities of this product candidate. The agreement is expected to contribute over $20 million to Cambrex’s revenues in 2013 and potentially even more in 2014, depending on regulatory developments, the time of completion of Cambrex's...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee